Account
Inquiry
Tirzepatide 15mg is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist currently under investigation for type 2 diabetes treatment applications. As a research compound with CAS number 2023788-19-2, this peptide demonstrates significantly enhanced efficacy in glucose regulation and weight management compared to similar compounds.
Our Tirzepatide 15mg product is supplied as a high-purity lyophilized powder with 99.9% purity, packaged in sterile vials suitable for laboratory use. The compound, also known as LY3298176, has shown promising results in clinical research for its dual mechanism of action.
This product is intended for research purposes only and is not for human consumption. Researchers working on metabolic disorders, diabetes mechanisms, or novel therapeutic approaches will find Tirzepatide 15mg particularly valuable for its unique receptor binding profile.
The molecular structure of Tirzepatide 15mg (C225H348N48O68) has been carefully characterized to ensure batch-to-batch consistency. Each shipment includes complete analytical documentation to support your research requirements.
As a manufacturer specializing in peptide compounds, we offer Tirzepatide 15mg in various quantities to meet different research needs. Our production follows strict quality control protocols to deliver reliable research materials to the scientific community.
